ClinicalTrials.govpublic full text
LBH589 Plus Decitabine for Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukemia (AML)
leukemia, myeloid, acute, myelodysplastic syndromes, lbh589, decitabine, panobinostat, histone deacetylase, methylation, hypomethylation, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980572
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.